LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control

FDA Device Recall #Z-1451-2022 — Class II — June 24, 2022

Recall Summary

Recall Number Z-1451-2022
Classification Class II — Moderate risk
Date Initiated June 24, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm LumiraDx
Location Waltham, MA
Product Type Devices
Quantity 99 units

Product Description

LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control

Reason for Recall

Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.

Distribution Pattern

Domestic: AR, CA, FL, MA, MD, NC, NJ, NV, NY, OK, TN, TX, & WI.

Lot / Code Information

No UDI codes. Catalog No. L017080109002. Lot No. 2002201428 (Exp. 01-Sept-2022).

Other Recalls from LumiraDx

Recall # Classification Product Date
Z-1970-2023 Class II SteriPack Sterile Polyester Spun Swabs (25 unit... Apr 25, 2023
Z-0135-2023 Class III LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality... Sep 23, 2022
Z-1450-2022 Class II LumiraDx SARS-CoV-2 Antibody (Ab) Test Strip Jun 24, 2022
Z-1312-2021 Class II Coronavirus antigen detection test system - Pro... Feb 3, 2021
Z-1132-2021 Class II LumiraDx SARS-CoV-2 Ag Test Strip Kit US EUA (4... Jan 11, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.